Literature DB >> 20859645

Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

Johannes K-H Meier1, Daniel Wolff, Steve Pavletic, Hildegard Greinix, Martin Gosau, Hartmut Bertz, Stefanie J Lee, Anita Lawitschka, Sharon Elad.   

Abstract

Chronic graft-versus-host disease (cGVHD) is a multi-organ disease that occurs post-hematopoietic stem cell transplantation, with the mouth being one of the most frequently affected organs. In 2009, the German-Austrian-Swiss working party on bone marrow and blood stem cell transplantation held a consensus conference to define clinical management of cGVHD. The consensus conference aimed to summarize the literature on diagnosis and topical treatment options for oral cGVHD and to provide recommendations for clinical practice, including routine dental and oral care as well as monitoring for secondary malignancies and bisphophonate-induced osteonecrosis of the jaw.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20859645     DOI： 10.1007/s00784-010-0450-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN： 1432-6981            Impact factor:   3.573


  84 in total

Review 1.  Analysis of new diagnostic methods in suspicious lesions of the oral mucosa.

Authors:  Anna Trullenque-Eriksson; Marta Muñoz-Corcuera; Julián Campo-Trapero; Jorge Cano-Sánchez; Antonio Bascones-Martínez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2009-05-01

2.  American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.

Authors:  Giuseppe Colella; Giuseppina Campisi; Vittorio Fusco
Journal:  J Oral Maxillofac Surg       Date:  2009-12       Impact factor: 1.895

3.  Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.

Authors:  Paul A Carpenter; Mark M Schubert; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2006-07       Impact factor: 5.742

Review 4.  Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management.

Authors:  A Majorana; M M Schubert; F Porta; A G Ugazio; P L Sapelli
Journal:  Support Care Cancer       Date:  2000-09       Impact factor: 3.603

5.  Electrostimulating device in the management of xerostomia.

Authors:  F P Strietzel; R Martín-Granizo; S Fedele; L Lo Russo; M Mignogna; P A Reichart; A Wolff
Journal:  Oral Dis       Date:  2007-03       Impact factor: 3.511

6.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

7.  Oral manifestations of chronic graft-v-host disease.

Authors:  M M Schubert; K M Sullivan; T H Morton; K T Izutsu; D E Peterson; N Flournoy; E L Truelove; G E Sale; C D Buckner; R Storb
Journal:  Arch Intern Med       Date:  1984-08

8.  Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.

Authors:  D Wolff; V Anders; R Corio; T Horn; W L Morison; E Farmer; G B Vogelsang
Journal:  Photodermatol Photoimmunol Photomed       Date:  2004-08       Impact factor: 3.135

Review 9.  Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature.

Authors:  Lauren L Patton; Joel B Epstein; A Ross Kerr
Journal:  J Am Dent Assoc       Date:  2008-07       Impact factor: 3.634

10.  Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.

Authors:  R W Martin; E R Farmer; V L Altomonte; G B Vogelsang; G W Santos
Journal:  Arch Dermatol       Date:  1995-03
View more
  25 in total

1.  [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

2.  Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.

Authors:  James S Young; Tao Wu; Yuhong Chen; Dongchang Zhao; Hongjun Liu; Tangsheng Yi; Heather Johnston; Jeremy Racine; Xiaofan Li; Audrey Wang; Ivan Todorov; Defu Zeng
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

3.  Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.

Authors:  C W Bassim; H Fassil; J W Mays; D Edwards; K Baird; S M Steinberg; K M Williams; E W Cowen; S A Mitchell; K Cole; T Taylor; D Avila; D Zhang; D Pulanic; L Grkovic; D Fowler; R E Gress; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2013-09-02       Impact factor: 5.483

4.  Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.

Authors:  Joseph DePalo; Xiaoyu Chai; Stephanie J Lee; Corey S Cutler; Nathaniel Treister
Journal:  Oral Oncol       Date:  2015-08-12       Impact factor: 5.337

Review 5.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

6.  Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers.

Authors:  Sharon Elad; Siri Beier Jensen; Judith E Raber-Durlacher; Nancy Mouradian; Elvira M P Correa; Mark M Schubert; Nicole M A Blijlevens; Joel B Epstein; Deborah P Saunders; Tuomas Waltimo; Noam Yarom; Yehuda Zadik; Michael T Brennan
Journal:  Support Care Cancer       Date:  2014-11-23       Impact factor: 3.603

7.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

8.  Oral disease profiles in chronic graft versus host disease.

Authors:  C W Bassim; H Fassil; J W Mays; D Edwards; K Baird; S M Steinberg; E W Cowen; H Naik; M Datiles; P Stratton; R E Gress; S Z Pavletic
Journal:  J Dent Res       Date:  2015-03-04       Impact factor: 6.116

Review 9.  Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study.

Authors:  Andrea Piccin; Mario Tagnin; Cinzia Vecchiato; Ahmad Al-Khaffaf; Lisa Beqiri; Caroline Kaiser; Iris Agreiter; Giovanni Negri; Michael Kob; Angela Di Pierro; Fabio Vittadello; Guido Mazzoleni; Klaus Eisendle; Fabrizio Fontanella
Journal:  Int J Hematol       Date:  2018-08-24       Impact factor: 2.490

10.  Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.

Authors:  Tao Wu; James S Young; Heather Johnston; Xiong Ni; Ruishu Deng; Jeremy Racine; Miao Wang; Audrey Wang; Ivan Todorov; Jianmin Wang; Defu Zeng
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.